Jim Cramer Says This Former Covid Market Favorite May Finally Be Invested Again
modern Expanding the portfolio beyond infectious diseases is giving investors a new reason to own stocks after years of uncertainty…
Spdr S&P Biotech Etf
Abivax shares soar after new data on drugs for intestinal diseases
Shares of a French biotechnology company Abivax surged on Tuesday after it released new data on its lead drug for…
Biotech IPO window is open, but big pharma M&As set the pace: bankers
Public markets are beginning to reopen for biotech companies after several years of subdued activity. But stronger companies are still…
Lilly, Novo and Pfizer seek new weight loss drugs
Drug makers have only been introducing GLP-1 pills for a few months and are undergoing big changes to the way…
Novartis, Amgen and Eli Lilly's Lp(a) Drugs Aim to Prevent Heart Attacks
Pharma believes it has found the next frontier in heart attack prevention. Novartis, amgen and Eli Lilly are among drugmakers…
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.…
The European pharmaceutical industry is in danger from Trump's policies and China's biotech boom
Boxes of medicines are seen on the shelves of Keencare pharmacy, a member of the Green Light Group, on September…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
How CNBC Cures is bringing rare disease stories to a national audience
Last summer, my sister Becky approached me with an idea. He wanted my help to build a platform on CNBC…
Vertex kidney drug Povetacicept succeeds in IgAN trial
A sign hangs in front of Vertex Pharmaceuticals' global headquarters in Boston. Brian Snyder | Reuters Vertex Pharmaceuticals said its…